Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the status of EGFR, ROS1 and MET genes in non-small cell lung adenocarcinoma.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology - 1 Jan 2000

Wang Qiong, Lv Yali, Zhong Mei, Zhu Fengwei, Wei Lixin, Shi Huaiyin

Abstract excerpt

PURPOSE: To investigate the status and distribution of epidermal growth factor receptor (EGFR), hepatocyte growth factor receptor (MET), and receptor tyrosine kinase (ROS1) genes in patients with non-small cell lung (NSCL) adenocarcinoma. METHODS: The copy number of the MET gene was detected using fluorescence in situ hybridization (FISH). The splice mutation in exon 14 gene was detected by Sanger sequencing. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gene Amplification

Share to In Situ Hybridization, Fluorescence

Share to Protein-Tyrosine Kinases

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-met

Source

Identifiers

PMID: 28952227

Genes

MET
EGFR
ROS1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the status of EGFR, ROS1 and MET genes in non-small cell lung adenocarcinoma.PMID 28952227Read ↗

Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review.Semantic proximity Read ↗

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectivesSemantic proximity Read ↗

Evaluation of ROS1 expression and rearrangements in a large cohort of early- stage lung cancerSemantic proximity Read ↗

Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.Semantic proximity Read ↗

[Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation].Semantic proximity Read ↗

High prevalence of ROS1 gene rearrangement detected by FISH in EGFR and ALK negative lung adenocarcinoma.Semantic proximity Read ↗

Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions.Semantic proximity Read ↗

[Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].Semantic proximity Read ↗

[Detection of ROS1 fusion gene in pulmonary adenocarcinoma and its clinicopathologic features].Semantic proximity Read ↗

[Clinicopathological significance in non-small cell lung cancer with mutations and co-mutations of EGFR, ALK and ROS1].Semantic proximity Read ↗

Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusionsSemantic proximity Read ↗

[Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.